KATHLEEN DIBBLE: Open Payments
NPI 1619407244 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 24 payments from 6 companies in 2025. Trend: 2023 $383 · 2024 $303 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $222 |
| Supernus Pharmaceuticals, Inc. | 13 | $133 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| ABBVIE INC. | 4 | $115 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: Auvelity, Qelbree, COBENFY, INGREZZA, VRAYLAR, Jornay PM.
Industry payments across FL — which companies pay providers there.
